Skip to contentBaker Bros. Capital (GP), LLC — VIROPHARMA INC insider: 193 transactions · InsiderLensBaker Bros. Capital (GP), LLC
- Director at INCYTE CORP · on record since Feb 2, 2007
- 10% owner at IDERA PHARMACEUTICALS, INC. · on record since Mar 28, 2006
- Director at TRIMERIS INC · on record since Feb 2, 2007
- 10% owner at TRIMERIS INC · on record since Feb 2, 2007
- 10% owner at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Feb 28, 2006
- 10% owner at VIROPHARMA INC · on record since Mar 1, 2006
- 10% owner at TAPESTRY PHARMACEUTICALS, INC · on record since Apr 20, 2006
- 10% owner at ALLOS THERAPEUTICS INC · on record since Nov 17, 2006
- Director at GENOMIC HEALTH INC · on record since Feb 21, 2007
- 10% owner at GENOMIC HEALTH INC · on record since Feb 21, 2007
- 10% owner at AUXILIUM PHARMACEUTICALS INC · on record since Mar 11, 2010
- Director at SEATTLE GENETICS INC /WA · on record since Feb 16, 2007
- 10% owner at SEATTLE GENETICS INC /WA · on record since Feb 16, 2007
- Director at NEUROGEN CORP · on record since Feb 2, 2007
- 10% owner at NEUROGEN CORP · on record since Feb 2, 2007
- 10% owner at BIOCRYST PHARMACEUTICALS INC · on record since Aug 8, 2007
- 10% owner at ALTEON INC /DE · on record since Aug 3, 2007
- 10% owner at INCYTE CORP · on record since Dec 19, 2007
- 10% owner at AP PHARMA INC /DE/ · on record since Oct 28, 2009
- 10% owner at ADOLOR CORP · on record since Apr 28, 2010
- 10% owner at VAXGEN INC · on record since Jul 29, 2010
- Director at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Jul 5, 2011
Insider trading activity of Baker Bros. Capital (GP), LLC
- Transactions on record
- 193
- since Sep 23, 2003
- Open-market buys
- 101
- $227.1K
- Open-market sells
- 50
- $2M
- Companies traded
- 14
- last filing Jan 31, 2012
Figures computed from official regulatory filings — methodology.
Companies where Baker Bros. Capital (GP), LLC has traded
Track record of Baker Bros. Capital (GP), LLC
Statistical track record
Free- Open-market buys
- 123
- Last buy
- Apr 24, 2011
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Baker Bros. Capital (GP), LLC
Co-insiders of Baker Bros. Capital (GP), LLC
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
12 tx · $7.9K · Jan 23, 2009
Baker Biotech Capital II (Z) (GP), LLCGENOMIC HEALTH INC +7
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jan 31, 2012 | Sell | -59,340 | 0.22 USD | $13.1K | SEC |
| Jan 20, 2012 | Sell | -20,000 | 0.20 USD | $4K | SEC |
| Jan 20, 2012 | Sell | -118,800 | 0.21 USD | $24.9K | SEC |
| Jan 4, 2012 | OtherD | -68,006 | 0.00 USD | $0 | SEC |
| Jan 4, 2012 | Other | 68,006 | 6.25 USD | $425K | SEC |
| Jul 5, 2011 | Other | -9,301 | 0.00 USD | $0 | SEC |
| Jul 5, 2011 | Other | -11,664 | 0.00 USD | $0 | SEC |
| Jul 5, 2011 | Other | -10,766 | 0.00 USD | $0 | SEC |
| Apr 26, 2011 | BuyD | 300 | 300.00 USD | $90K | SEC |
| Apr 26, 2011 | BuyD | 600 | 0.00 USD | $0 | SEC |
| Mar 31, 2011 | Buy | 309 | 21.98 USD | $6.8K | SEC |
| Aug 11, 2010 | Sell | -3,938 | 14.09 | $55.5K | SEC |
| Aug 11, 2010 | Sell | -6,053 | 14.08 | $85.2K | SEC |
| Aug 11, 2010 | Sell | -956 | 14.00 | $13.4K | SEC |
| Aug 11, 2010 | Sell | -1,856 | 14.00 | $26K | SEC |
| Aug 17, 2009 | Buy | 33 | 19.99 | $659.7 | SEC |
| Aug 17, 2009 | Buy | 1 | 19.60 | $19.6 | SEC |
| Jun 1, 2009 | Sell | -3,124 | 3.89 | $12.2K | SEC |
| Jun 1, 2009 | Sell | -8,067 | 3.86 | $31.1K | SEC |
| Jun 1, 2009 | Sell | -1,500 | 4.30 | $6.5K | SEC |
| Jun 1, 2009 | Sell | -7,726 | 4.12 | $31.8K | SEC |
| Jun 1, 2009 | Sell | -6,174 | 4.45 | $27.5K | SEC |
| Jun 1, 2009 | Sell | -11,128 | 4.50 | $50.1K | SEC |
| May 20, 2009 | Buy | 3,710 | 9.72 | $36.1K | SEC |
| May 15, 2009 | Buy | 190 | 5.46 | $1K | SEC |